4//SEC Filing
Ghias Babar 4
Accession 0000882796-25-000038
CIK 0000882796other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:11 PM ET
Size
6.9 KB
Accession
0000882796-25-000038
Insider Transaction Report
Form 4
Ghias Babar
CFO & Head of Corp Development
Transactions
- Award
Common Stock
2025-12-17+121,700→ 268,700 total - Award
Emp. Stock Option (Right to Buy)
2025-12-17+355,050→ 355,050 totalExercise: $7.13From: 2026-12-17Exp: 2035-12-17→ Common Stock (355,050 underlying)
Footnotes (2)
- [F1]Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0002076862
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:11 PM ET
- Size
- 6.9 KB